Repository logo
 
Publication

Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper

dc.contributor.authorBaiardini, I
dc.contributor.authorBraido, F
dc.contributor.authorBindslev-Jensen, C
dc.contributor.authorBousquet, PJ
dc.contributor.authorBrzoza, Z
dc.contributor.authorCanonica, GW
dc.contributor.authorCompalati, E
dc.contributor.authorFiocchi, A
dc.contributor.authorFokkens, W
dc.contributor.authorGerth van Wijk, R
dc.contributor.authorGiménez-Arnau, A
dc.contributor.authorGodse, K
dc.contributor.authorGrattan, C
dc.contributor.authorGrobb, JJ
dc.contributor.authorLa Grutta, S
dc.contributor.authorKalogeromitros, D
dc.contributor.authorKocaturk, E
dc.contributor.authorLombardi, C
dc.contributor.authorMota-Pinto, A
dc.contributor.authorRidolo, E
dc.contributor.authorSaini, SS
dc.contributor.authorSanchez-Borges, M
dc.contributor.authorSenna, GE
dc.contributor.authorTerreehorst, I
dc.contributor.authorTodo-Bom, A
dc.contributor.authorToubi, E
dc.contributor.authorBousquet, J
dc.contributor.authorZuberbier, T
dc.contributor.authorMaurer, M
dc.date.accessioned2011-11-29T11:02:52Z
dc.date.available2011-11-29T11:02:52Z
dc.date.issued2011
dc.description.abstractThe aim of this Global Allergy and Asthma European Network (GA(2)LEN) consensus report is to provide recommendations and suggestions for assessing patient-reported outcomes (PROs) including health-related quality of life in patients with urticaria. We recommend that PROs should be used both in clinical trials and routine practice for the evaluation of urticaria patients. We suggest that PROs should be considered as the primary outcome of future clinical trials. Two validated and disease-specific instruments for assessing PROs are available, the urticaria activity score (for symptoms) and the chronic urticaria questionnaire on quality of life CU-Q(2)oL. This latter tool, CU-Q(2)oL, is available in many languages and should be preferred, where available, over more generic instruments for assessing urticaria-specific effects on quality of life. CU-Q(2)oL is only suited for the investigation of patients with chronic spontaneous urticaria. Similar instruments for other forms of urticaria have yet to be developed and validated. Also, tools for assessing other chronic spontaneous urticaria PROs besides quality of life and symptoms are needed.por
dc.identifier.citationAllergy. 2011 Jul;66(7):840-4.por
dc.identifier.urihttp://hdl.handle.net/10400.4/1173
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherWileypor
dc.subjectUrticáriapor
dc.subjectQualidade de Vidapor
dc.titleRecommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paperpor
dc.typejournal article
dspace.entity.typePublication
rcaap.rightsopenAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Allergy.pdf
Size:
123.76 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections